Business Russia held a meeting of Russian and Chinese pharmaceutical and medical manufacturers

A delegation of high-tech and innovative companies from China, including representatives of AstraZeneca China, Dipath, Amoy Diagnostic visited Business Russia. The Chinese group also includes firms specializing in the development and implementation of solutions in the field of AI, diagnostics in healthcare, preclinical and clinical research, CAR-T technologies, production of biological drugs and medical products.

During the visit, a round table was held on Russian-Chinese cooperation and the introduction of high technologies in domestic healthcare. Nonna Kagramanyan, Vice President and Head of the Executive Committee of Business Russia, told foreign entrepreneurs about the Russia-China business dialogue that the Russian business community organized at the WEF, as well as about the signing of a memorandum of cooperation with the Chinese International Trade Promotion Committee. "Our cooperation is reaching a new level – we have signed agreements with almost all the largest business associations in China, and we are constantly adjusting the roadmaps of interaction. The work of Business Russia and China is accompanied in the country by the business ambassador of Business Russia, Alexander Suchkov, as well as with the help of business associations – our partners. Thus, for Business Russia, cooperation with China is one of the priority areas of international cooperation. I hope that the meeting will allow Russian and Chinese companies to agree on the implementation of innovative projects and strengthen cooperation between the two countries in the field of healthcare," Nonna Kagramanyan said.

In turn, the members of the General Council of Business Russia told their Chinese colleagues about their developments and opportunities for cooperation. Pavel Nosov, Managing Director of Medipal Group, spoke about the work of the organization, which produces more than 100 types of drugs for the treatment of oncology, rare diseases, diseases of the endocrine and immune systems. Lyudmila Zakharova, co-founder and CEO of Akross Group, presented a project to automate the laboratory service of medical organizations.